Frontier Capital Management CO LLC Supernus Pharmaceuticals, Inc. Transaction History

Frontier Capital Management CO LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$27.57 - $32.91 $55,140 - $65,820	-2,000 Reduced 0.99%	200,653 $5.53 Million
Q2 2023 Aug 14, 2023	SELL	$29.91 - $38.73 $3.06 Million - $3.97 Million	-102,426 Reduced 33.57%	202,653 $6.09 Million
Q1 2023 May 15, 2023	SELL	$34.93 - $42.03 $12.2 Million - $14.7 Million	-350,653 Reduced 53.48%	305,079 $11.1 Million
Q4 2022 Feb 14, 2023	SELL	$31.09 - $37.88 $1.46 Million - $1.78 Million	-47,076 Reduced 6.7%	655,732 $23.4 Million
Q3 2022 Nov 14, 2022	BUY	$28.79 - $35.41 $2.49 Million - $3.06 Million	86,433 Added 14.02%	702,808 $23.8 Million
Q2 2022 Jul 20, 2022	SELL	$25.33 - $34.25 $886,043 - $1.2 Million	-34,980 Reduced 5.37%	616,375 $17.8 Million
Q1 2022 Apr 14, 2022	BUY	$28.51 - $32.9 $959,475 - $1.11 Million	33,654 Added 5.45%	651,355 $21.1 Million
Q4 2021 Jan 19, 2022	BUY	$26.37 - $34.22 $1.02 Million - $1.32 Million	38,628 Added 6.67%	617,701 $18 Million
Q3 2021 Oct 19, 2021	SELL	$23.54 - $31.39 $5.59 Million - $7.46 Million	-237,658 Reduced 29.1%	579,073 $15.4 Million
Q2 2021 Aug 09, 2021	BUY	$26.72 - $33.19 $1.26 Million - $1.57 Million	47,208 Added 6.13%	816,731 $25.1 Million
Q1 2021 May 13, 2021	BUY	$24.15 - $31.45 $18.6 Million - $24.2 Million	769,523 New	769,523 $20.1 Million

283

60.6M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.11B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Capital Management CO LLC with notifications on news.